Natural Cytotoxicity Triggering Receptor 1 (NCR1) Antibody
260€ (50 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Natural Cytotoxicity Triggering Receptor 1 (NCR1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx456536
tested applications
ELISA, WB, IHC
Description
Natural Cytotoxicity Triggering Receptor 1 (NCR1) Antibody is a Rabbit polyclonal antibody for the detection of Mouse Natural Cytotoxicity Triggering Receptor 1 (NCR1).
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Natural Cytotoxicity Triggering Receptor 1 (NCR1) |
| Host | Rabbit |
| Reactivity | Mouse |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Size 1 | 50 µg |
| Size 2 | 100 µg |
| Form | Liquid |
| Tested Applications | ELISA, WB, IHC |
| Buffer | 0.01 M PBS, pH 7.4, 50% glycerol, 0.05% Proclin-300. |
| Availability | Shipped within 5-12 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | Q8C567 |
| Gene ID | 17086 |
| NCBI Accession | NP_034876.2 |
| Alias | Lymphocyte antigen 94 homolog,LY94,CD335,NKP46,NK-p46,NK cell-activating receptor,Natural killer cell p46-related protein |
| Background | Antibody anti-NCR1 |
| Status | RUO |
Descripción
Related Products
Anti-NCR1 antibody
The natural cytotoxicity receptors (NCRs) are a recently characterized family of Ig-like activation receptors that appear to be major triggering receptors in tumor cell recognition. NCR1 is a glycoprotein that has two extracellular Ig-like domains followed by a ~40 amino acid residue stalk region, a type I transmembrane domain, and a short cytoplasmic tail. NCR1 has been shown to represent a novel NK cell-specific molecule involved in human NK cell activation. NCR1 has been implicated in NK cell-mediated lysis of several autologous tumor cells and pathogen-infected cell lines.
Ver Producto
Recombinant Human NCR1
Ver Producto